Literature DB >> 26180132

Effective transfer of a 47 kb NDM-1-positive plasmid among Acinetobacter species.

Tzu-Wen Huang1, Tsai-Ling Lauderdale2, Tsai-Lien Liao1, Ming-Chia Hsu3, Feng-Yee Chang4, Shan-Chwen Chang5, Wei Xin Khong6, Oon Tek Ng6, Ying-Tsong Chen7, Shu-Chen Kuo2, Te-Li Chen8, Jung-Jung Mu9, Shih-Feng Tsai10.   

Abstract

OBJECTIVES: To investigate the link between two NDM-1-positive Acinetobacter isolates from the same hospital, the plasmid profiles of the isolates were examined. These two isolates were found from a surveillance programme within 3 months from two patients without obvious physical contact or hospitalization time overlap.
METHODS: Antimicrobial susceptibility tests, genome sequencing of both isolates and plasmid transfer experiments were performed. A comparative study of similar plasmids was performed using BLAST analysis.
RESULTS: The antimicrobial susceptibility of the isolates (Acinetobacter soli M131 and Acinetobacter pittii MS32) and their Escherichia coli transconjugants revealed a conjugative plasmid that carried the carbapenem resistance determinant. Eleven plasmids were observed in M131 and three in MS32. Each isolate shared an identical plasmid that carried the blaNDM-1 gene. This 47 271 bp plasmid harbours a conserved blaNDM-1-containing region that is flanked by ISAba125 and ISAba11 elements, and also contains a Ti-type conjugative operon. The plasmid is nearly identical in sequence to those of Acinetobacter isolates from China. In contrast to the mobilization of the blaNDM-1 sequence in Enterobacteriaceae, which is mainly by transposition, this plasmid moves as a whole among Acinetobacter species. Consistently, this plasmid was found to transfer effectively by in vitro conjugation to several Acinetobacter species.
CONCLUSIONS: The clinical and laboratory findings suggest that Acinetobacter species may serve as a reservoir of this blaNDM-1 plasmid. Our study demonstrates the potential of applying genome sequencing to the surveillance of antimicrobial-resistant bacteria.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26180132     DOI: 10.1093/jac/dkv191

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  The tet39 Determinant and the msrE-mphE Genes in Acinetobacter Plasmids Are Each Part of Discrete Modules Flanked by Inversely Oriented pdif (XerC-XerD) Sites.

Authors:  Grace A Blackwell; Ruth M Hall
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

2.  Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.

Authors:  Yi-Tzu Lee; Yung-Chih Wang; Shu-Chen Kuo; Chung-Ting Chen; Chang-Pan Liu; Yuag-Meng Liu; Te-Li Chen; Ya-Sung Yang
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Transmission and characterization of bla NDM-1 in Enterobacter cloacae at a teaching hospital in Yunnan, China.

Authors:  Na Du; Shumin Liu; Min Niu; Yong Duan; Shuangmeng Zhang; Jing Yao; Jian Mao; Ran Chen; Yan Du
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-08-22       Impact factor: 3.944

4.  Detection of co-harboring OXA-58 and NDM-1 carbapenemase producing genes resided on a same plasmid from an Acinetobacter pittii clinical isolate in China.

Authors:  Yili Chen; Penghao Guo; Han Huang; Yongxin Huang; Zhongwen Wu; Kang Liao
Journal:  Iran J Basic Med Sci       Date:  2019-01       Impact factor: 2.699

5.  An NDM-1-Producing Acinetobacter towneri Isolate from Hospital Sewage in China.

Authors:  Kaiying Wang; Peihan Li; Jinhui Li; Xiaofeng Hu; Hui Ma; Yanfeng Lin; Lang Yang; Shaofu Qiu; Peng Li; Hongbin Song
Journal:  Infect Drug Resist       Date:  2020-04-16       Impact factor: 4.003

6.  Genomic characterization of triple-carbapenemase-producing Acinetobacter baumannii.

Authors:  Ken-Ichi Oinuma; Masato Suzuki; Arata Sakiyama; Taishi Tsubouchi; Kozo Saeki; Kanako Sato; Mamiko Niki; Koichi Yamada; Keigo Shibayama; Hiroshi Kakeya; Yukihiro Kaneko
Journal:  JAC Antimicrob Resist       Date:  2021-12-18

7.  In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital.

Authors:  Yongyut Lertsrisatit; Wichai Santimaleeworagun; Sudaluck Thunyaharn; Jantima Traipattanakul
Journal:  Infect Drug Resist       Date:  2017-11-20       Impact factor: 4.003

8.  Genomic Epidemiology of NDM-1-Encoding Plasmids in Latin American Clinical Isolates Reveals Insights into the Evolution of Multidrug Resistance.

Authors:  Ricaurte Alejandro Marquez-Ortiz; Leanne Haggerty; Narda Olarte; Carolina Duarte; Ulises Garza-Ramos; Jesus Silva-Sanchez; Betsy E Castro; Eby M Sim; Mauricio Beltran; María V Moncada; Alberto Valderrama; Jaime E Castellanos; Ian G Charles; Natasha Vanegas; Javier Escobar-Perez; Nicola K Petty
Journal:  Genome Biol Evol       Date:  2017-06-01       Impact factor: 3.416

9.  Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in Vivo.

Authors:  Kyoungeun Cha; Hynu K Oh; Jae Y Jang; Yunyeol Jo; Won K Kim; Geon U Ha; Kwan S Ko; Heejoon Myung
Journal:  Front Microbiol       Date:  2018-04-10       Impact factor: 5.640

10.  Role of plasmid carrying bla NDM in mediating antibiotic resistance among Acinetobacter baumannii clinical isolates from Egypt.

Authors:  Alaa Abouelfetouh; Aisha S Torky; Elsayed Aboulmagd
Journal:  3 Biotech       Date:  2020-03-16       Impact factor: 2.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.